Annual General Meeting

Annual General Meeting

Annual General Meeting 2020

This section contains relevant materials regarding our Annual General Meeting (AGM). Due to the coronavirus pandemic, our first AGM as a public company will be held on Friday June 26, 2020 at 10:00 a.m. (CET) in the form of a virtual general meeting without the presence of shareholders or their proxies.

The full meeting can be viewed live using the password-protected Internet Portal specifically created for this purpose. A link to the Internet Portal will be posted here in due course.

Further details about how shareholders can exercise their voting rights and ask questions can be found in the participation conditions in the Invitation to the AGM.

 

DOCUMENTS AND INFORMATION FOR THE VIRTUAL AGM

Invitation to the 2020 Annual General Meeting

Invitation to the 2020 AGM Convenience Translation

 

Documents relating to Agenda Item 1

BioNTech SE Jahresabschluss 2019

BioNTech SE Konzernabschluss 2019

BioNTech SE Lagebericht 2019

BioNTech Konzernlagebericht 2019

Bericht des Aufsichtsrats zum Geschäftsjahr 2019

 

Explanation to Agenda Item 1

Explanatory Notes on Agenda Item 1 s124a sentence 1 no. 2 Stock Corporation Act (AktG)

 

Documents relating to Agenda Item 6

Report of the Management Board on the Exclusion of Subscription Rights

 

Documents relating to Agenda Items 6 and 7

BioNTech SE Articles of Association Convenience Translation

 

Documents relating to Agenda Item 8

Sample Domination Agreement Convenience Translation

Sample Domination and Profit and Loss Transfer Agreement Convenience Translation

BioNTech IVAC GmbH (vormals Business Services) GuV und Bilanz 2017-2019

BioNTech Real Estate Holding GmbH (vormals AptaIT) GuV und Bilanz 2017-2019

BioNTech Small Molecules GmbH GuV und Bilanz 2017-2019

BioNTech Cell & Gene Therapies GmbH GuV und Bilanz 2017-2019

JPT Peptide Technologies GmbH GuV und Bilanz 2017-2019

Domination Agreement BioNTech IVAC GmbH Joint Report Convenience Translation

Domination Agreement BioNTech Real Estate Holding GmbH Joint Report Convenience Translation

Domination Agreement BioNTech Small Molecules GmbH Joint Report Convenience Translation

Domination and Profit and Loss Transfer Agreement BioNTech Cell & Gene GmbH Joint Report Convenience Translation

Domination and Profit and Loss Transfer Agreement JPT Peptide Technologies GmbH Joint Report Convenience Translation

 

Further Information and Forms

Explanatory Notes on Shareholders’ Rights

Registration, Voting and Proxy Form

 

Total Number of Shares and Voting Rights

Total Number of Shares and Voting Rights

 

Countermotions and Election Proposals

There are currently no countermotions and election proposals from shareholders.